This inventor holds 59 USPTO granted patents and 51 published patent applications, plus 12 CIPO patents and 33 EPO patents, primarily in Bispecific Antibodies (CPC class C07K). Top assignees: Hoffmann-La Roche Inc., Lts Lohmann Therapie-Systeme Ag, Boehringer Mannheim Gmbh. Active years: 1998-2026.
Inventors with similar research interests:
Location History:
- St. Augustin, DE (2003)
- Madison, NJ (US) (2007 - 2013)
- Mannhein, DE (2015)
- Frankfurt-am-Main, DE (2014 - 2016)
- Mannheim, DE (1998 - 2024)
Company Filing History:
49 out of 5,011 
5 out of 333 
1 out of 1,164 
Years Active: 1998-2026
Areas of Expertise:
Title: Innovations and Contributions of Wolfgang Schaefer in the Field of Antibodies
Introduction: Wolfgang Schaefer, based in Mannheim, Germany, is a prolific inventor with an impressive portfolio of 50 patents. His work primarily focuses on advancements in therapeutic antibodies, which have significant implications in the medical field, particularly in the treatment of diseases such as cancer.
Latest Patents: Among his most recent innovations are the "Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use." This patent presents novel antibodies that target both human CD20 and the human transferrin receptor, showcasing a new approach in targeted therapy. Additionally, his work on "Multispecific antibodies" introduces antibodies with at least three antigen binding sites, emphasizing the sophistication of his research. This patent includes methods for production, pharmaceutical compositions, and various uses of these advanced antibodies.
Career Highlights: Wolfgang Schaefer has had a distinguished career, serving in key roles at notable companies such as Hoffmann-La Roche Inc. His contributions in these positions have propelled advancements in biopharmaceutical research and development, solidifying his reputation as a leader in the field.
Collaborations: Throughout his career, Schaefer has collaborated with esteemed colleagues, including Christian Klein and Joerg Thomas Regula. These partnerships fostered a rich exchange of ideas, enhancing the innovation process and leading to breakthroughs in antibody technology.
Conclusion: Wolfgang Schaefer's contributions to the field of antibodies through his numerous patents reflect his dedication to advancing medical science. His innovative approaches and collaborative spirit continue to influence the development of effective therapeutic solutions, highlighting the vital role of inventors in driving progress in healthcare.